We have located links that may give you full text access.
COMPARATIVE STUDY
JOURNAL ARTICLE
Operative treatment of meralgia paresthetica: transection versus neurolysis.
Neurosurgery 1995 July
The question of the superior operative technique for meralgia paresthetica is unsettled. Operative treatment by either neurolysis or transection of the lateral femoral cutaneous nerve was performed in 21 patients with meralgia paresthetica after complete failure of conservative treatment; neurolysis in 10 patients and transection in 11 patients were performed by five neurosurgeons. The average follow-up period was 74 months (+/- 52 mo). The results were scored as complete relief, partial relief, or failure. Direct comparison of neurolysis and transection confirmed the superiority of transection as a treatment for meralgia paresthetica (Mann-Whitney-U test, P = 0.022; one-sample sign test, P = 0.0020).
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app